Skip to content

Robotic Versus Video-assisted Lobectomy/Segmentectomy for Lung Surgery

Robotic Versus Video-assisted Lobectomy/Segmentectomy for Lung Surgery

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05270616
Enrollment
800
Registered
2022-03-08
Start date
2020-06-01
Completion date
2028-06-01
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Diseases, Surgery

Keywords

robotic surgery, VATS, uniport, multiport

Brief summary

To compare the safety/efficacy of the robotic-assisted lobectomy/segmentectomy (RAL/S) with the video-assisted lobectomy/segmentectomy (VAL/S) for lung resection. Video-assisted lobectomy/segmentectomy (VAL/S) for lung resection is divided into uniport group and multiple- port group.

Interventions

PROCEDURErobotic surgery

minimally invasive surgery using the Davinci robotic system

PROCEDUREuniport surgery

VATS minimally invasive surgery under the uniportal status

PROCEDUREmultiple- port surgery

VATS minimally invasive surgery under the multiple- port status

Sponsors

The Second Hospital of Shandong University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. good cardio- pulmonary function to tolerate surgery; 2. minimaly invasive surgery for lobectomy or segmentectomy or sleeve lobectomy;

Exclusion criteria

1. cardio- pulmonary function is not good enough to tolerate surgery; 2. huge tumor or extensive adhesion in thoracic cavity.

Design outcomes

Primary

MeasureTime frameDescription
mortality30 days after surgeryincidence rate
conversion rate to open surgeryduring surgeryincidence rate
postoperative complicationswithin 7 days after surgeryincidence rate
operation timewithin 180 minutesminutes
duration of hospitalizationwithin 7 days after surgerydays
days to tube removalwithin 7 days after surgerydays
retrieved lymph nodewithin 1 days after surgeryamount
retrieved lymph node stationwithin 1 days after surgeryamount
short- term PFS3 yearsproportion
short- term overall survival3 yearsproportion

Countries

China

Contacts

Primary ContactXiaogang Zhao
zhaoxiaogang@sdu.edu.cn+8617660080007
Backup ContactYunpeng Zhao
zyp_baggio@163.com18766188692

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026